AIRLINK 72.80 Increased By ▲ 0.62 (0.86%)
BOP 5.06 Increased By ▲ 0.13 (2.64%)
CNERGY 4.33 Decreased By ▼ -0.02 (-0.46%)
DFML 30.52 Increased By ▲ 2.03 (7.13%)
DGKC 85.95 Increased By ▲ 4.65 (5.72%)
FCCL 22.35 Increased By ▲ 0.85 (3.95%)
FFBL 33.22 Increased By ▲ 0.17 (0.51%)
FFL 9.78 Decreased By ▼ -0.08 (-0.81%)
GGL 10.40 Decreased By ▼ -0.08 (-0.76%)
HBL 113.62 Decreased By ▼ -0.38 (-0.33%)
HUBC 136.20 Decreased By ▼ -3.80 (-2.71%)
HUMNL 10.03 Increased By ▲ 1.00 (11.07%)
KEL 4.66 Decreased By ▼ -0.07 (-1.48%)
KOSM 4.40 Increased By ▲ 0.02 (0.46%)
MLCF 38.35 Increased By ▲ 0.70 (1.86%)
OGDC 133.40 Decreased By ▼ -0.30 (-0.22%)
PAEL 27.40 Increased By ▲ 1.80 (7.03%)
PIAA 24.76 Increased By ▲ 0.78 (3.25%)
PIBTL 6.55 Increased By ▲ 0.07 (1.08%)
PPL 121.21 Decreased By ▼ -1.41 (-1.15%)
PRL 27.15 Increased By ▲ 0.08 (0.3%)
PTC 13.89 Increased By ▲ 0.29 (2.13%)
SEARL 60.40 Increased By ▲ 3.78 (6.68%)
SNGP 68.53 Decreased By ▼ -0.71 (-1.03%)
SSGC 10.33 Decreased By ▼ -0.01 (-0.1%)
TELE 9.05 Increased By ▲ 0.60 (7.1%)
TPLP 11.26 Decreased By ▼ -0.02 (-0.18%)
TRG 65.70 Increased By ▲ 4.49 (7.34%)
UNITY 25.25 Decreased By ▼ -0.08 (-0.32%)
WTL 1.50 No Change ▼ 0.00 (0%)
BR100 7,608 Decreased By -22.2 (-0.29%)
BR30 25,091 Increased By 100.6 (0.4%)
KSE100 72,658 Increased By 56.2 (0.08%)
KSE30 23,383 Decreased By -155.9 (-0.66%)
Markets

S&P 500, Dow pull back from all-time highs; eyes on stimulus talks

  • Energy shares firm about 1% as oil prices rise.
  • Lowe's jumps on $15 bln share buy-back plan.
  • Indexes down: Dow 0.2%, S&P 500 0.2%, Nasdaq 0.2%.
Published December 10, 2020

The S&P 500 and the Dow eased from record levels on Wednesday as investors kept an eye out for developments related to a fresh economic stimulus deal, with negotiations between government leaders dragging on.

Investors are banking on a long-awaited relief package to mitigate the economic damage from the COVID-19 pandemic that has led to millions of layoffs and overwhelmed the healthcare system.

US Senate Majority Leader Mitch McConnell said lawmakers were still looking for a path toward an agreement on COVID-19 aid, as the US House of Representatives prepared to vote on a one-week funding bill to provide more time for a deal.

"We had a pretty nice boost in the morning on speculation that we might get a new package, but it's kind of an on-again and off-again thing," said Randy Frederick, vice president of trading and derivatives for Charles Schwab in Austin, Texas.

Positive updates on the COVID-19 vaccine development have recently lifted Wall Street's main indexes to all-time highs, with the S&P 500 surpassing 37,000 points for the first time on Tuesday.

Johnson & Johnson extended gains from the previous session, when it said it could obtain late-stage trial results for a single-dose vaccine in January, earlier than expected.

With overall valuations now at extremely high levels, some investors worry stocks could be more vulnerable to any bad news such as unexpected setbacks in the roll-out of coronavirus vaccines or delays in stimulus.

"Markets need to digest, trade range bound and have all investors that are very optimistic hone back a little bit. We believe that the business cycle is still in the early innings of a new uptick," said Andrew Smith, chief investment strategist at Delos Capital Advisors in Dallas.

Real estate and utilities sectors posted the sharpest percentage declines. Energy stocks firmed about 1%, tracking higher oil prices.

By 11:32 a.m. ET, the Dow Jones Industrial Average was down 72.68 points, or 0.24%, at 30,101.20, the S&P 500 was down 7.48 points, or 0.20%, at 3,694.77 and the Nasdaq Composite was down 29.45 points, or 0.23%, at 12,553.33.

Shares of DoorDash Inc were set to soar in their debut on Wednesday after the food delivery startup raised $3.37 billion in one of the biggest US stock market launches so far in 2020.

Home improvement chain Lowe's Cos Inc jumped 6% after announcing a new $15 billion share repurchase plan.

Drugmaker Eli Lilly advanced 4% after flagging positive data for its experimental drug from a late-stage diabetes clinical trial.

Advancing issues outnumbered decliners for a 1.2-to-1 ratio on the NYSE, while declining issues outnumbered advancers for a 1.1-to-1 ratio on the Nasdaq.

The S&P 500 posted 36 new 52-week highs and no new low, while the Nasdaq recorded 384 new highs and 14 new lows.

Comments

Comments are closed.